Recruiting
Phase 2

Glofitamab & Pirtobrutinib

Sponsor:

C. Babis Andreadis

Code:

NCT06252675

Conditions

Mantle Cell Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Obinutuzumab

Glofitamab

Pirtobrutinib

Tumor Imaging

Biospecimen Collection

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-29. This information was provided to ClinicalTrials.gov by C. Babis Andreadis on 2025-07-25.